AGEN Total Utang marang Modal Agenus, Inc
Agenus (AGEN) minimizes losses from individual trial failures through a broad pool of partnerships with global corporations. The price action of the total debt-to-equity ratio, which currently stands at 0.00, complements revenue data from the development of cancer immunotherapy agents. The business is currently undergoing rigorous cost optimization and a strategic pivot toward the sale of its core oncology drugs.
Rincian analitis lan laporan data perusahaan Agenus, Inc (AGEN)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Analisis komprehensif perusahaan:AGEN - Agenus Inc.
The financial stability of Agenus (AGEN) depends on the balance between R&D expenditures and external financing. An analysis of the company's debt-to-equity ratio allows for an assessment of the business's reliance on borrowed funds. This metric is calculated as the sum of all liabilities divided by shareholders' equity. For a biotech firm, this is critical: licensing payments from partners must cover the debt load. An optimal leverage level confirms investment attractiveness and the fair value of assets.
Pesaing utama
Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas gossamerbio.com (GOSS)|KALV: Total Utang marang Modal|Utang marang Modal Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc - Total Utang marang Modal|SVRA - Total Utang marang Modal|Total Utang marang Modal RIGL (Rigel Pharmaceuticals)|anaptysbio.com (ANAB) - Rasio Utang marang Modal|Total Utang marang Modal ATXS (Astria Therapeutics, Inc.)|Utang marang Modal ENGN|Utang marang Ekuitas RAPT Therapeutics, Inc. RAPT|Rasio Utang marang Ekuitas aerovatetx.com JBIO|Rasio Total Utang marang Ekuitas ACRS (Aclaris Therapeutics)|kyvernatx.com - Total Utang marang Modal|Utang marang Ekuitas TLSA (Tiziana Life Sciences Ltd)|CABA - Koefisien Total Utang marang Modal|VTYX: Total Utang marang Modal|Theratechnologies, Inc (THTX) - Total Utang marang Modal|Avalo Therapeutics, Inc - Total Utang marang Modal|Rasio Utang marang Modal eledon.com|Climb Bio - Total Utang marang Modal|Utang marang Modal ZURA (Zura Bio Ltd)|ATYR - Utang marang Ekuitas|Adagene Inc - Rasio Utang marang Ekuitas|Utang marang Ekuitas Ikena Oncology, Inc.|STTK - Utang Agregat marang Ekuitas|Total Utang marang Modal equilliumbio.com EQ|Connect Biopharma Holdings Limited (CNTB) - Rasio Kabeh Utang marang Dana Pribadi|IMUX (Immunic Therapeutics) - Total Utang marang Modal|Total Utang marang Modal ATRA|InflaRx N.V. (IFRX) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi XFOR (x4pharma.com)|Adicet Bio, Inc. - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celularity Inc CELU|INmune Bio Corp - Total Utang marang Modal|Barinthus Biotherapeutics Corp (BRNS) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Kezar Life Sciences KZR|sabbiotherapeutics.com (SABS) - Rasio Kabeh Utang marang Dana Pribadi|AKTX: Total Utang marang Modal|Koefisien Total Utang marang Modal ENLV|Utang marang Ekuitas QTTB (Q32 Bio Inc.)|Rasio Total Utang marang Ekuitas GOVX (GeoVax Corp)|Edesa Biotech, Inc. - Utang marang Ekuitas|IBIO - Rasio Total Utang marang Ekuitas|Carisma Tx - Rasio Total Utang marang Ekuitas|XTLB: Total Utang marang Modal|Utang marang Ekuitas boltbio.com|HCW Biologics (HCWB) - Rasio Utang marang Ekuitas|Total Utang marang Modal APVO (Aptevo Therapeutics, Inc.)|Utang marang Modal AIM ImmunoTech, Inc.|Total Utang marang Modal ADTX|Total Utang marang Modal GRI Bio Inc (GRI)|XRTX (XORTX) - Total Utang marang Modal|Rasio Utang marang Modal Vyome Therapeutics HIND|REVB (Revelation Biosciences) - Total Utang marang Modal|INDP: Utang marang Modal|Utang marang Ekuitas Scinai Immunotherapeutics Ltd.|Rasio Utang marang Ekuitas CalciMedica|AFMD (Affimed NV) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ALLK|HOOK (HOOKIPA Pharma Inc.) - Utang marang Ekuitas|Koefisien Total Utang marang Modal igmbio.com (IGMS)|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Total Utang marang Modal Ocean Biomedical Inc OCEA|Total Utang marang Modal TCBP|THRD - Rasio Utang marang Modal